These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6925459)

  • 41. An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by Corynebacterium parvum.
    Bomford R
    Int J Cancer; 1977 May; 19(5):673-9. PubMed ID: 863546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with C. parvum.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basíc I; Milas L
    Dev Biol Stand; 1977 Apr 13-15; 38():297-300. PubMed ID: 608514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy with biochemically dissociated fractions of Propionibacterium acnes in a murine ovarian cancer model.
    Berek JS; Cantrell JL; Lichtenstein AK; Hacker NF; Knox RM; Nieberg RK; Poth T; Elashoff RM; Lagasse LD; Zighelboim J
    Cancer Res; 1984 May; 44(5):1871-5. PubMed ID: 6713388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. III. Tumor growth inhibition by local delayed hypersensitivity reactions to unrelated antigens.
    Palladino MA; Thorbecke GJ
    Eur J Immunol; 1978 Apr; 8(4):257-62. PubMed ID: 668800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
    Keller R
    J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.
    Suit HD; Sedlacek RS; Silobrcic V; Linggood RM
    Cancer; 1976 Jun; 37(6):2573-9. PubMed ID: 949676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rate of tumour inhibition by activated macrophages in vitro.
    Orinda DA
    East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
    [No Abstract]   [Full Text] [Related]  

  • 52. Restoration by levamisole of immune responses suppressed in tumor-bearing mice.
    Shiraishi M; Himeno K; Nomoto K
    Cancer Immunol Immunother; 1983; 15(2):121-5. PubMed ID: 6553512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of C. parvum and specific immunization against artificial pulmonary metastases in mice.
    Milas L; Kogelnik HD; Basic I; Mason K; Hunter N; Withers HR
    Int J Cancer; 1975 Nov; 16(5):738-46. PubMed ID: 1184241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanism of Inhibition of immunization with irradiated tumour cells by a large dose of Corynebacterium parvum.
    Woodruff M; Whitehead VL
    Proc R Soc Lond B Biol Sci; 1977 Jul; 197(1129):505-14. PubMed ID: 18742
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 57. Host-mediated antitumor activity of Lactobacillus casei in mice.
    Yasutake N; Kato I; Ohwaki M; Yokokura T; Mutai M
    Gan; 1984 Jan; 75(1):72-80. PubMed ID: 6427051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of the type I hypersensitivity late phase reaction to OVA by Propionibacterium acnes-soluble polysaccharide.
    Squaiella CC; Longhini AL; Braga EG; Mussalem JS; Ananias RZ; Yendo TM; Straus AH; Toledo MS; Takahashi HK; Hirata IY; Longo-Maugéri IM
    Immunol Lett; 2008 Dec; 121(2):157-66. PubMed ID: 19014971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of antimetastatic effect against Lewis lung carcinoma after intratumoral and intravenous injections of cell-wall skeleton of Propionibacterium acnes C7 in C57BL/6 mice.
    Tanio Y; Sohma H; Tokushima Y; Nishimura K; Saiki I; Azuma I
    Gan; 1984 Mar; 75(3):237-44. PubMed ID: 6609859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay.
    Gabizon A; Small M; Trainin N
    Int J Cancer; 1976 Dec; 18(6):813-9. PubMed ID: 992909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.